Articles for Vectura Group (LSE: VEC)

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Why Vectura group plc and GlaxoSmithKline plc could be the perfect combination

GlaxoSmithKline plc (LON: GSK) and Vectura Group plc (LON: VEC) have many complementary qualities. More »

Should You Ditch GlaxoSmithKline plc And Buy Vectura Group PLC And SkyePharma PLC?

Are these 2 pharmaceutical stocks better buys that GlaxoSmithKline plc (LON: GSK)? Check out Vectura Group PLC (LON: VEC) and SkyePharma PLC (LON: SKP). More »

Are Vectura Group PLC, AstraZeneca plc And Lookers PLC ‘Screaming Buys’?

Should you add these 3 stocks to your portfolio? Vectura Group PLC (LON: VEC), AstraZeneca plc (LON: AZN) and Lookers PLC (LON: LOOK) More »

Are Vectura Group PLC And Circassia Pharmaceuticals PLC Better Buys Than GlaxoSmithKline plc?

Should you add Vectura Group PLC (LON: VEC) and Circassia Pharmaceuticals PLC (LON: CIR) to your portfolio before GlaxoSmithKline plc (LON: GSK)? More »

Why Vectura Group PLC Could Be The Perfect Partner For AstraZeneca plc In Your Portfolio

These 2 pharmaceutical companies look set to soar: Vectura Group PLC (LON: VEC) and AstraZeneca plc (LON: AZN) More »

Profit From The Biotech Boom With Vectura Group PLC, Hikma Pharmaceuticals Plc And Indivior PLC

Vectura Group PLC (LON:VEC), Hikma Pharmaceuticals Plc (LON:HIK) and Indivior PLC (LON:INDV) are three top plays on the biotech boom. More »

Your browser (Internet Explorer 8 or older) is out of date. It has known security flaws and may not display all features of this and other websites. We recommend updating to Google Chrome.